| Up
2004P-0320: REFRAIN
FROM APPROVING CERTAIN APPLICATIONS SUBMITTED UNDER SECTION 505(B)(2)
OF THE FDCA THAT REFERENCE DEPAKOTE (DIVALPROEX SODIUM DELAYED-
RELEASE TABLETS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 07/15/2004
|
| 07/15/2004
|
| Drug Industry
|
| Abbott Laboratories
|
|
|
|
|
|
|
| pdf,
Tab1, Tab2,
Tab3, Tab4,
Tab5
|
|
|
|
|
| Signature:
|
| David M. Fox
|
|
|
|
|
| ACK1
|
| 07/15/2004
|
| 07/15/2004
|
| Federal
Government
|
| HFA-305 to Abbott
Laboratories
|
|
|
|
|
|
|
| doc,
pdf
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
|
|
|
|
|
|
| LET1
|
| 08/03/2004
|
| 08/03/2004
|
| Drug Industry
|
| Abbott Laboratories
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| David M. Fox
|
|
|
|
|
| C1
|
| 11/01/2004
|
| 10/29/2004
|
| Drug Industry
|
| Andrx Laboratories,
Inc. (Andrx)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| David L. Rosen, B.S.Pharm.,J.D.
| |
|
|
|
| LET2
|
| 01/12/2005
|
| 01/12/2005
|
| Federal
Government
|
| HFD-005 to Hogan &
Hartson
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
|
| RC1
|
| 03/04/2005
|
| 03/04/2005
|
| Drug Industry
|
| Abbott Laboratories
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| David M. Fox
|
|
|
|
|
| WDL1
|
| 07/21/2006
|
| 07/21/2006
|
| Drug Industry
|
| Abbott Laboratories
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| David M Fox
| |
Top | Up
Page last updated
August 10, 2006
kk |
